Pricing Log in Create free account
Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

ONC Healthcare Biotechnology

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue
+33.8%
EPS
+143.7%
Free cash flow
+33.6%
Total debt
+491.3%

Quarter to September 2026, against a year earlier

409.11 21.86 +5.64%
Market cap
$40.4B
P/E
65.9×
Fwd P/E
48.8×
Dividend yield
—
F-score
7/9
Altman Z
5.25
Beneish M
−2.73
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR (ONC) Debt to equity

Alert me on Debt to equity

BeOne Medicines Ltd. - Sponsored ADR's debt to equity at the end of the quarter to 30 September 2026 was 0.1×, down 0.1× from fiscal 2025 (0.2×). Over the past ten years it has ranged from 0.0× (fiscal 2016) to 0.3× (fiscal 2019); the current reading is higher than 82% of that period. That is above the Biotechnology industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.2× 341.20%
FY2024 0.1× (10.55%)
FY2023 0.1× (54.48%)
FY2022 0.1× 15.63%
FY2021 0.1× (22.88%)
FY2020 0.1× (46.42%)
FY2019 0.3× 127.23%
FY2018 0.1× (53.01%)
FY2017 0.2× 391.22%
FY2016 0.0× (41.18%)

Quarterly newest first

Period Debt to equity Change
Sep 2026 0.1× (16.83%)
Jun 2026 0.2× (15.68%)
Mar 2026 0.2× (8.34%)
Dec 2025 0.2× 552.66%
43 more quarters

Against its own ten years

Low 0.0× High 0.3×
Ten-year median 0.1×
Current reading's percentile 82

Debt to equity against peers

Company Debt to equity
ROIV Roivant Sciences Ltd. compare 0.0×
ARGX argenex SE compare 0.0×
RVMD Revolution Medicines, Inc. compare 0.0×
INCY Incyte Corporation compare 0.0×
BNTX BioNTech SE Sponsored ADR compare 0.0×
ONC BeOne Medicines Ltd. - Sponsored ADR 0.1×
INSM Insmed, Inc. compare 0.8×
GMAB Genmab A/S Sponsored ADR compare 0.9×
RPRX Royalty Pharma PLC compare 0.9×
Biotechnology industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on ONC